Azilsartan
279/NRP-001
Approved small_molecule completed
Quick answer
Azilsartan for Essential Hypertension Complicated by Type 2 Diabetes Mellitus is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Essential Hypertension Complicated by Type 2 Diabetes Mellitus
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed